The use of newer antidepressants for panic disorder

Journal of Clinical Psychiatry

Volumn 58, Issue SUPPL. 14, 1997, Pages 54-58

  Gorman, Jack M ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CLOMIPRAMINE; CLONAZEPAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; LORAZEPAM; MAPROTILINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; SERTRALINE; VENLAFAXINE;

ASTHENIA; BEHAVIOR THERAPY; CARDIOTOXICITY; CLINICAL TRIAL; DROWSINESS; DRUG CHOICE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG POTENCY; HEADACHE; HUMAN; HYPERHIDROSIS; ORTHOSTATIC HYPOTENSION; PANIC; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; TREATMENT PLANNING; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

1-NAPHTHYLAMINE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZODIAZEPINES; CLINICAL TRIALS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOHEXANOLS; FLUOXETINE; FLUVOXAMINE; HUMANS; MONOAMINE OXIDASE INHIBITORS; PANIC DISORDER; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 0031459909     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Klein DF, Fink M. Psychiatric reaction patterns to imipramine. Am J Psychiatry 1962;119:432-438
2. West ED, Dally PJ. Effects of iproniazid in depressive syndromes. BMJ 1959;1:1491
3. Sargant W, Dally P. Treatment of anxiety states by antidepressant drugs. BMJ 1962;1:6-9
4. Kelly D, Guirguis W, Frommer E, et al. Treatment of phobic states with antidepressants: a retrospective study of 246 patients. Br J Psychiatry 1970; 116:387-398
5. Gloger S, Grunhaus L, Birmacher B, et al. Treatment of spontaneous panic attacks with clomipramine. Am J Psychiatry 1981;138:1215-1217
6. Grunhaus L, Gloger S, Birmacher B. Clomipramine treatment for panic attacks in patients with mitral valve prolapse. J Clin Psychiatry 1984;45: 25-27
7. Sheehan DV, Ballenger J, Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 1980;37:51-59
8. Bigger JT Jr, Fleiss JL, Steinman RC, et al. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-171
9. Bakish D, Saxena BM, Bowen R, et al. Reversible monoamine oxidase-A inhibitors in panic disorder. Clin Neuropharmacol 1993;16(suppl 2):77-82
10. Garcia-Borreguero D, Lauer CJ, Ozdaglar A, et al. Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A. Pharmacopsychiatry 1992;25:261-264
11. Ballenger JC, Burrows GD, DuPont RI, et al. Alprazolam in panic disorder and agoraphobia, I: efficacy in short-term treatment. Arch Gen Psychiatry 1988;45:413-422
12. Briggs AC, Stretch DD, Brandon S. Subtyping of panic disorder by symptom profile. Br J Psychiatry 1993;163:201-209
13. Beauclair L, Fontaine R, Annable L, et al. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response. J Clin Psychopharmacol 1994;14:111-118
14. Schweizer E, Pohl R, Balon R, et al. Lorazepam vs alprazolam in the treatment of panic disorder. Pharmacopsychiatry 1990;23:90-93
15. Rickels K, Schweizer E, Weiss S, et al. Maintenance drug treatment for panic disorder, II: short- and long-term outcome after drug taper. Arch Gen Psychiatry 1988;50:61-68
16. Otto MW, Pollack MH, Sachs GS, et al. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry 1993;150:1485-1495
17. Spiegal DA, Bruce TJ, Gregg SF, et al. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry 1994;151:876-881
18. Gorman JM, Liebowitz MR, Fyer AJ, et al. An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 1987;7:329-332
19. Louie AK, Lewis TB, Lannon RA. Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry 1993;54:435-438
20. Schneier FR, Liebowitz MR, Davies SO, et al. Fluoxetine in panic disorder. J Clin Psychopharmacol 1990;10:119-121
21. Tiffon L, Coplan JD, Papp LA, et al. Augmentation strategies with tricyclic or fluoxetine in seven partially responsive panic disorder patients. J Clin Psychiatry 1994;55:66-69
22. Westenberg HGM, den Boer JA. Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder. Psychopharmacol Bull 1989;25:119-123
23. Hoehn-Saric R, McLeod DR, Hipsley PA. Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 1993;13:321-326
24. Black DW, Wesner R, Bowers W, et al. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993;50:44-50
25. Black DW, Wesner R, Gabel J. The abrupt discontinuation of fluvoxamine in patients with panic disorder. J Clin Psychiatry 1993;54:146-149
26. de Beurs E, van Balkom AJLM, Lange A, et al. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am J Psychiatry 1995;152:683-691
27. LeCrubier Y. A double-blind, placebo-controlled study of paroxetine and clomipramine in the treatment of panic disorder. Presented at the annual meeting of the Anxiety Disorders Association of America: April 1995; Pittsburgh, Pa
28. Steiner M, Oakes R, Gergel IP, et al. A fixed dose study of paroxetine and placebo in the treatment of panic disorder. In: New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association; May 24, 1995; Miami Beach, Fla. Abstract NR355:150
29. Oehrberg S, Christiansen PE, Behnke K, et al. Paroxetine in the treatment of panic disorder: a randomized, double-blind, placebo-controlled study. Br J Psychiatry 1995;167:374-379
30. Gorman JM, Wolkow R. Sertraline as a treatment for panic disorder. Presented at the biannual meeting of the Collegium Internationale Neuro-Psychopharmacologicum; June 1994; Washington, DC
31. Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995;10:45-49
32. Gorman JM, Papp LA, Coplan JD. Neuroanatomy and neurotransmitter function in panic disorder. In: Roose SP, Glick RA, eds. Anxiety: Symptom and Signal. Hillsdale, NJ: Analytic Press; 1995
33. Coplan JD, Papp LA, Pine DS, et al. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Arch Gen Psychiatry 1997;54:643-648
34. Geracioti TD. Venlafaxine treatment of panic disorder: a case series. J Clin Psychiatry 1995;56:408-410
35. Papp LA, Sinha S, Coplan JD, et al. Low-dose venlafaxine treatment in the treatment of panic disorder. Psychopharmacol Bull. In press